Non-alcoholic Steatohepatitis (NASH) is a serious form of liver disease, part of the spectrum of Non-alcoholic Fatty Liver Disease (NAFLD). It is characterized by the accumulation of fat in liver cells, inflammation, and liver cell damage. NASH can progress to more severe liver damage, including fibrosis (scarring), cirrhosis, and even liver cancer. The exact causes of NASH are not completely understood, but it is often associated with metabolic conditions such as type 2 diabetes, obesity, and high cholesterol or triglycerides. Diagnosis typically involves blood tests, imaging techniques, and sometimes a liver biopsy. There are no specific treatments for NASH, so management usually focuses on addressing underlying metabolic issues, such as through lifestyle changes like diet and exercise, and weight loss. The increasing global prevalence of obesity and metabolic syndrome has made Nonalcoholic Steatohepatitis (NASH) a growing public health concern worldwide.